WBA logo

Walgreens Boots Alliance (WBA)

Profile

Full Name

Walgreens Boots Alliance, Inc.

Ticker Symbol

WBA

Exchange

NASDAQ

Sector

Healthcare

Industry

Pharmaceutical Retailers

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.walgreensbootsalliance.com

Employees

193000

Key Details

Price

$10.91(+1.21%)

Market cap

$9.43B(Mid cap)

Last Dividend

$0.25

TTM Dividend yield

6.87%

Annual revenue

$147.66B(+6.17% YoY)

Annual EPS

-$10.01(-180.39% YoY)

PE ratio

-

Next earnings date

Jun 27, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.91
WBA price is $10.91

30-Day Relative Volume

0.57
WBA 30-day relative volume is 0.57

Price Performance

Price Today change

+1.21%
WBA price is up +1.21% today

Price YTD change

+16.93%
WBA price is up +16.93% since January 1st

Price 1-year change

-38.88%
WBA price is down -38.88% year-on-year

Price 3-year change

-75.65%
WBA price is down -75.65% over the past 3 years

Price Range

Price All-time high

$97.30
WBA price is currently -88.79% below its historical high of $97.30

Price 3-year low

$8.08
WBA price is currently +35.02% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.43B
WBA market capitalization is $9.43 billion

Market cap 3-year change

-75.63%
WBA market capitalization is down -75.63% over the past 3 years

Market cap All-time high

$105.60B
WBA market capitalization is currently -91.07% below its historical high of $105.60 billion

Market cap sector rank

92.36%
WBA market capitalization is higher than 92.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.23%
WBA shares outstanding is up +0.23% year-on-year

Shares Outstanding 3-Year Change

+0.11%
WBA shares outstanding is up +0.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.19
WBA beta is 0.19

200-day SMA

$10.18
WBA price is currently +7.12% above its 200-day simple moving average

50-day SMA

$10.74
WBA price is currently +1.56% above its 50-day simple moving average

RSI

49.78
WBA 14-day relative strength index is 49.78

Volume

0.57
WBA 30-day relative volume is 0.57

ATR

$0.30
WBA average true range is $0.30

10-day Historical Volatility

23.61%
WBA 10-day historical volatility is 23.61%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.25
WBA last dividend was $0.25 per share, with an ex-dividend date of November 18, 2024

Next Dividend

-
WBA next dividend has not yet been announced

Dividend per share

Dividend per share

$1.23
WBA annual dividend per share is $1.23

Dividend per share Sector Rank

52.33%
WBA annual dividend per share is higher than 52.33% of companies in Healthcare sector

Dividend per share 1-Year Change

-35.94%
WBA annual dividend per share is down -35.94% year-on-year

Dividend per share 3-Year Change

-34.57%
WBA annual dividend per share is down -34.57% over the past 3 years

Dividend yield

Dividend yield

11.27%
WBA annual dividend yield is 11.27%

Dividend yield Sector Rank

94.12%
WBA annual dividend yield is higher than 94.12% of companies in Healthcare sector

Other

Payout ratio

-14.59%
WBA annual payout ratio is -14.59%

Dividends paid

$1.26B
WBA annual dividends paid is $1.26 billion

Free cash flow

-$363.00M
WBA annual free cash flow is -$363.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$147.66B
WBA annual revenue is $147.66 billion

Revenue Analysts estimate

$151.56B
WBA annual revenue is currently -2.58% lower than the consensus analysts' forecast

Revenue 1-year change

+6.17%
WBA annual revenue is up +6.17% year-on-year

Revenue Sector rank

99.1%
WBA annual revenue is higher than 99.1% of companies in Healthcare sector

EPS

EPS

-$10.01
WBA annual earnings per share is -$10.01

EPS Analysts estimate

$1.66
WBA annual earnings per share is currently -701.67% lower than the consensus analysts' forecast

EPS 1-year change

-180.39%
WBA annual earnings per share is down -180.39% year-on-year

EPS Sector rank

12.3%
WBA annual earnings per share is higher than 12.3% of companies in Healthcare sector

Profit

Gross profit

$26.52B
WBA annual gross profit is $26.52 billion

Gross margin

17.96%
WBA annual gross profit margin is 17.96%

Operating profit

-$1.59B
WBA annual operating income is -$1.59 billion

Operating margin

-1.08%
WBA annual operating profit margin is -1.08%

Net income

-$8.64B
WBA annual net profit is -$8.64 billion

Net margin

-5.85%
WBA annual net profit margin is -5.85%

Expenses

Total expenses

$149.25B
WBA annual total expenses is $149.25 billion

Operating expenses

$28.11B
WBA annual total operating expenses is $28.11 billion

Cost of goods sold

$121.13B
WBA annual cost of goods sold is $121.13 billion

Selling, general & administrative expenses

$28.11B
WBA annual SGA is $28.11 billion

Depreciation and amortization

$2.46B
WBA annual depreciation & amortization is $2.46 billion

Interest expense

$482.00M
WBA annual interest expense is $482.00 million

Income tax

$1.25B
WBA annual income tax is $1.25 billion

EBIT & EBITDA

EBIT

-$13.74B
WBA annual earnings before interest & taxes is -$13.74 billion

EBITDA

-$11.28B
WBA annual EBITDA is -$11.28 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$81.04B
WBA annual total assets is $81.04 billion

Non current assets

$62.70B
WBA annual long term assets is $62.70 billion

Current assets

$18.34B
WBA annual total current assets is $18.34 billion

Cash and cash equivalents

$1.32B
WBA annual cash & cash equivalents is $1.32 billion

Accounts receivable

$5.85B
WBA annual accounts receivable is $5.85 billion

Inventory

$8.32B
WBA annual inventory is $8.32 billion

Liabilities

Total liabilities

$68.86B
WBA annual total liabilities is $68.86 billion

Long term liabilities

$41.90B
WBA annual total long term liabilities is $41.90 billion

Current liabilities

$26.95B
WBA annual total current liabilities is $26.95 billion

Accounts payable

$14.08B
WBA annual accounts payable is $14.08 billion

Debt

Total debt

$32.85B
WBA annual total debt is $32.85 billion

Total debt 1-year change

-2.03%
WBA annual total debt is down -2.03% year-on-year

Long term debt

$28.96B
WBA annual long term debt is $28.96 billion

Short term debt

$3.89B
WBA annual short term debt is $3.89 billion

Equity & Capital

Shareholders equity

$10.45B
WBA annual stockholders equity is $10.45 billion

Book value

$10.45B
WBA annual book value is $10.45 billion

Retained earnings

$23.35B
WBA annual retained earnings is $23.35 billion

Working capital

-$8.62B
WBA annual working capital is -$8.62 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.02B
WBA annual cash flow from operations is $1.02 billion

Cash from operations 1-year change

-54.92%
WBA annual cash flow from operations is down -54.92% year-on-year

Cash from investing

$1.88B
WBA annual cash flow from investing activities is $1.88 billion

Cash from investing 1-year change

+160.7%
WBA annual cash flow from investing activities is up +160.7% year-on-year

Cash from financing

-$538.00M
WBA annual cash flow from financing activities is -$538.00 million

Cash from financing 1-year change

+39.35%
WBA annual cash flow from financing activities is up +39.35% year-on-year

CAPEX

CAPEX

$1.38B
WBA annual capital expenditures is $1.38 billion

CAPEX 1-year change

-34.77%
WBA annual capital expenditures is down -34.77% year-on-year

Free Cash Flow

Free cash flow

-$363.00M
WBA annual free cash flow is -$363.00 million

Free cash flow 1-year change

-357.45%
WBA annual free cash flow is down -357.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

17.96%
WBA annual gross profit margin is 17.96%

Operating margin

-1.08%
WBA annual operating profit margin is -1.08%

Net margin

-5.85%
WBA annual net profit margin is -5.85%

ROA & ROE

ROA

-9.72%
WBA annual return on assets is -9.72%

ROE

-42.47%
WBA annual return on equity is -42.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
WBA price to earnings ratio value is unknown

PE ratio Sector rank

-
WBA price to earnings ratio is unknown

PB Ratio

PB ratio

1.33
WBA price to book ratio is 1.33

PB ratio Sector rank

51.4%
WBA price to book ratio is higher than 51.4% of companies in Healthcare sector

PS Ratio

PS ratio

0.06
WBA price to sales ratio is 0.06

PS ratio Sector rank

4.1%
WBA price to sales ratio is higher than 4.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$38.87B
WBA enterprise value is $38.87 billion

Enterprise value Sector rank

97.19%
WBA enterprise value is higher than 97.19% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-15.12
WBA EV/EBITDA is -15.12

EV/EBITDA Sector rank

8.08%
WBA EV/EBITDA is higher than 8.08% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.68
WBA annual current ratio is 0.68

Quick ratio

0.37
WBA annual quick ratio is 0.37

Leverage

Debt to equity

0.91
WBA annual debt to equity ratio is 0.91

Interest coverage ratio

-28.50
WBA annual interest coverage ratio is -28.50

Risk & Stability

Piotroski F-Score

4
WBA piotroski f-score is 4

Altman Z-Score

1.62
WBA altman z-score is 1.62

Analyst ratings

Recent major analysts updates

Feb 28, 25 Deutsche Bank
Sell
Jan 31, 25 Truist Securities
Hold
Jan 16, 25 Truist Securities
Hold
Jan 15, 25 RBC Capital
Sector Perform
Jan 13, 25 Evercore ISI Group
In-Line
Jan 13, 25 B of A Securities
Underperform
Dec 4, 24 RBC Capital
Sector Perform
Oct 23, 24 Jefferies
Hold
Oct 22, 24 TD Cowen
Buy
Oct 17, 24 UBS
Neutral

Institutional Ownership

Similar stocks

NBIX logo
Neurocrine Biosciences (NBIX)
ASND logo
Ascendis Pharma A/S (ASND)
MEDP logo
Medpace Holdings (MEDP)
ATR logo
AptarGroup (ATR)
QGEN logo
Qiagen NV (QGEN)
VTRS logo
Viatris (VTRS)
DOCS logo
Doximity (DOCS)
EXEL logo
Exelixis (EXEL)
GMED logo
Globus Medical (GMED)
  • What is the ticker symbol for Walgreens Boots Alliance?
  • Does Walgreens Boots Alliance pay dividends?
  • What sector is Walgreens Boots Alliance in?
  • What industry is Walgreens Boots Alliance in?
  • What country is Walgreens Boots Alliance based in?
  • When did Walgreens Boots Alliance go public?
  • Is Walgreens Boots Alliance in the S&P 500?
  • Is Walgreens Boots Alliance in the NASDAQ 100?
  • Is Walgreens Boots Alliance in the Dow Jones?
  • When was Walgreens Boots Alliance's last earnings report?
  • When does Walgreens Boots Alliance report earnings?
  • Should I buy Walgreens Boots Alliance stock now?

What is the ticker symbol for Walgreens Boots Alliance?

The ticker symbol for Walgreens Boots Alliance is NASDAQ:WBA

Does Walgreens Boots Alliance pay dividends?

Yes, Walgreens Boots Alliance pays dividends. The last payment was $0.25, with an ex-dividend date on November 18, 2024

What sector is Walgreens Boots Alliance in?

Walgreens Boots Alliance is in the Healthcare sector

What industry is Walgreens Boots Alliance in?

Walgreens Boots Alliance is in the Pharmaceutical Retailers industry

What country is Walgreens Boots Alliance based in?

Walgreens Boots Alliance is headquartered in United States

When did Walgreens Boots Alliance go public?

Walgreens Boots Alliance's initial public offering (IPO) was on March 17, 1980

Is Walgreens Boots Alliance in the S&P 500?

Yes, Walgreens Boots Alliance is included in the S&P 500 index

Is Walgreens Boots Alliance in the NASDAQ 100?

No, Walgreens Boots Alliance is not included in the NASDAQ 100 index

Is Walgreens Boots Alliance in the Dow Jones?

No, Walgreens Boots Alliance is not included in the Dow Jones index

When was Walgreens Boots Alliance's last earnings report?

Walgreens Boots Alliance's most recent earnings report was on Apr 8, 2025

When does Walgreens Boots Alliance report earnings?

The next expected earnings date for Walgreens Boots Alliance is Jun 27, 2025

Should I buy Walgreens Boots Alliance stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page